STAPHYLOCOCCUS AUREUS NASAL CARRIAGE AMONG INJECTING AND NON-INJECTING DRUG USERS AND ANTIMICROBIAL SUSCEPTIBILITY

被引:0
|
作者
Varshochi, Mojtaba [1 ,2 ]
Attari, Zahra [2 ]
Hasani, Alka [3 ]
Seidi, Ali [4 ]
机构
[1] Tabriz Univ Med Sci, Fac Med, Res Ctr Infect Dis & Trop Med, Dept Infect Dis, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Med, Dept Infect Dis, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Med, Dept Microbiol, Tabriz, Iran
[4] Tabriz Univ Med Sci, Fac Med, Dept Psychiat, Tabriz, Iran
关键词
Staphylococcus Aureus; Drug Addicts; Nasal Carriers; Antimicrobial Susceptibility;
D O I
10.3844/ajidsp.2013.34.39
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Staphylococcus Aureus (SA) is one of the most prevalent bacterial pathogens in human beings. Approximately 20% of healthy persons are persistent carriers and 60% are intermittent carriers of SA. Nasal cavity is one of the most important sites of its colonization. Intravenous (IV) drug abuse has been proposed as a risk factor for colonization of SA in the nasal mucosa. The goal of this study was to determine the frequency of SA carriers in nasal cavity among IV and non-IV drug abusers (addicts), as well as to assess the antimicrobial susceptibility pattern of the positive cases. In a cross-sectional analysis of 300 drug addicts (Group I: 100 non-injecting addicts, Group II: 100 IV injecting drug addicts in rehab, Group III: 100 IV injecting drug addicts not in rehab) in the infectious diseases clinics of Tabriz's Imam Reza and Sina teaching hospitals and the rehabilitation center of Razi hospital, were investigated. Hospitalized addicts, insulin-dependent diabetic cases, HIV positive patients and those on chronic hemodialysis were excluded. The nasal mucosal sample was prepared from each case for SA isolation and its antimicrobial susceptibility was investigated by antibiogram. Eighty-four cases (28%) were culture positive for SA, including 26 cases in group one, 32 cases in group two and 26 cases in group three (p = 0.55). There was only one MRSA isolate present in all the cases studied (1.2%). No resistance to linozolid, rifampin and vancomycin was observed. The resistance to erythromycin, cefoxitin, ciprofloxacin, clindamycin, co-trimoxazol and gentamicin were 3.6, 4.8, 2.4, 3.6, 1.2 and 2.4% respectively. No statistically significant differences existed between the three groups in antibacterial susceptibility pattern. Sensitivity to oxacillin using the E-test results and disc diffusion were completely consistent. The percentage of carries of SA in the anterior nasal mucosa among IV and non-IV drug addicts is not considerably higher than the general population. MRSA isolates were uncommon in our cases. However, given the importance of localized and systemic infections in this group, early detection and treatment is reasonable.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 50 条
  • [21] Nasal Carriage and Antimicrobial Susceptibility Pattern of Staphylococcus aureus among Breastfeeding Mothers and their Infants
    Syahniar, Rike
    Anandani, Adinta
    Subiyatin, Aning
    Mubarok, Hanif Ahmad
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2024, 18 (02): : 1319 - 1325
  • [22] Seroprevalence of hepatitits B, hepatitits C, HIV, and syphilis infections among non-injecting drug users
    Mutlu, Elif Aktan
    Altintoprak, A. Ender
    Tokucoglu, Levent
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2015, 16 (01): : 65 - 68
  • [23] Are non-injecting opioid users at risk of transition to injecting drug use? A multi-site study from India
    Ambekar, Atul
    Mishra, Ashwani
    Parmar, Arpit
    Kumar, Rajesh
    Kumar, Manish
    Rao, Ravindra
    Agrawal, Alok
    ASIAN JOURNAL OF PSYCHIATRY, 2019, 42 : 79 - 84
  • [24] Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia
    Uuskuela, A.
    McMahon, J. M.
    Kals, M.
    Talu, A.
    Abel-Ollo, K.
    Rueuetel, K.
    Des Jarlais, D. C.
    AIDS AND BEHAVIOR, 2013, 17 (03) : 879 - 888
  • [25] High prevalence of HBV and HCV among injecting and non injecting drug users in Italy
    Camoni, L.
    Regine, V.
    Salfa, M. C.
    Raimondo, M.
    Bruning, A. H. L.
    Nicoletti, G.
    Canuzzi, P.
    Magliocchetti, N.
    Rezza, G.
    Suligoi, G.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2010, 20 : 207 - 207
  • [26] Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN cohort)
    Fischer, Benedikt
    Manzoni, Patrik
    Rehm, Jurgen
    EUROPEAN ADDICTION RESEARCH, 2006, 12 (04) : 230 - 239
  • [27] Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors
    Neaigus, A
    Miller, M
    Friedman, SR
    Hagen, DL
    Sifaneck, SJ
    Ildefonso, G
    Des Jarlais, DC
    ADDICTION, 2001, 96 (06) : 847 - 860
  • [28] Are non-injecting opioid users at risk of transition to injecting? A multisite study from North India
    Ambekar, Atul
    Kumar, Rajesh
    Kumar, Manish
    INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (05) : S79 - S80
  • [29] ASSESSING NON-INJECTING HEROIN USE IN BIRMINGHAM, UK: A COMPARISON OF CHARACTERISTICS AND REASONS FOR NON-INJECTING IN SAMPLES OF NEVER-INJECTED AND FORMERLY-INJECTING HEROIN USERS IN CONTACT WITH ADULT DRUG TREATMENT
    Smith, Alison C.
    Best, David
    Day, Ed
    JOURNAL OF DRUG ISSUES, 2009, 39 (03) : 477 - 493
  • [30] High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors)
    Valdez, Avelardo
    Neaigus, Alan
    Kaplan, Charles
    Cepeda, Alice
    DRUG AND ALCOHOL DEPENDENCE, 2011, 114 (2-3) : 233 - 236